| 2025-01-15 |
Activated single nucleotide mismatch determination through toehold-embedded hairpin-mediated strand displacement reaction alongside CRISPR-Cas12a for detection of TP53 point mutation |
Sensors and Actuators B-Chemical. 2025 Jan 15;423:Article number 136751. |
 |
| 2024-12 |
Integrating predictive coding and a user-centric interface for enhanced auditing and quality in cancer registry data |
Computational and Structural Biotechnology Journal. 2024 Dec;24:322-333. |
|
| 2024-11 |
Cytoplasmic lipid droplets predict worse prognosis in diffuse large B-cell lymphoma: Next-generation sequencing deciphering lipogenic genes |
American Journal of Surgical Pathology. 2024 Nov 1;48(11):1425-1438. |
|
| 2024-11 |
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: A cross-trial, patient-level analysis |
Lancet. Oncology. 2024 Nov;25(11):1465-1475. |
|
| 2024-10-11 |
Taiwan nationwide study of first-line ALK-TKI therapy in ALK-positive lung adenocarcinoma |
Targeted Oncology. 2024 Oct 11;Article in Press. |
|
| 2024-10-01 |
Special Issue "Bioinformatics study in human diseases: Integration of omics data for personalized medicine" |
International Journal of Molecular Sciences. 2024 Oct 01;25(19):Article number 10579. |
|
| 2024-10 |
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study |
Oncologist. 2024 Oct 3;29(10):e1396-e1405. |
|
| 2024-09-30 |
Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521 |
JCO Global Oncology. 2024 Sep 30;10:Article number e2400125. |
|
| 2024-09-27 |
DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer |
Oncogenesis. 2024 Sep 27;13:Article number 34. |
|
| 2024-09-26 |
The effectiveness of virtual passport, an app-based intervention, for dementia care |
Frontiers in Psychiatry. 2024 Sep 26;15:Article number 1457923. |
|
| 2024-09-20 |
The mitochondrial stress signaling tunes immunity from a view of systemic tumor microenvironment and ecosystem |
iScience. 2024 Sep 20;27(9):Article number 110710. |
|
| 2024-09-20 |
Evaluating a natural language processing–driven, AI-assisted international classification of diseases, 10th revision, clinical modification, coding system for diagnosis related groups in a real hospital environment: Algorithm development and validation st |
Journal of Medical Internet Research. 2024 Sep 20;26:Article number e58278. |
|
| 2024-09-18 |
Crosstalk between FTH1 and PYCR1 dysregulates proline metabolism and mediates cell growth in KRAS-mutant pancreatic cancer cells |
Experimental and Molecular Medicine. 2024 Sep 18;56:2065-2081. |
|
| 2024-09-10 |
Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma |
Breast Cancer Research. 2024 Sep 10;26:Article number 130. |
|
| 2024-09-05 |
BRCA genetic testing and counseling in breast cancer: How do we meet our patients' needs? |
npj Breast Cancer. 2024 Sep 05;10:Article number 77. |
|
| 2024-09-03 |
EMP2 induces cytostasis and apoptosis via the TGFBeta/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma (vol 44, pg 1133, 2021) |
Cellular Oncology. 2024 Sep 03;Article in Press. |
|
| 2024-09-03 |
The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma |
Asian Journal of Surgery. 2024 Sep 03;Article in Press. |
|
| 2024-08-28 |
Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab |
Journal of Clinical Oncology. 2024 Aug 28;Article in Press. |
|
| 2024-08-20 |
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 tri |
Gastric Cancer. 2024 Aug 20;Article in Press. |
|
| 2024-08-16 |
The miRNAs 203a/210-3p/5001-5p regulate the androgen/androgen receptor/YAP-induced migration in prostate cancer cells |
Cancer Medicine. 2024 Aug 16;13(16):Article number e70106. |
|
| 2024-08-06 |
Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer |
ESMO Open. 2024 Aug 06;9(8):Article number 103647. |
|
| 2024-08 |
Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin |
British Journal of Dermatology. 2024 Aug;191(2):252-260. |
|
| 2024-08 |
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): Updated overall survival from a randomised phase 3 study |
Lancet. Gastroenterology and Hepatology. 2024 Aug;9(8):694-704. |
|
| 2024-08 |
Photothermal temperature-modulated cancer metastasis harnessed using proteinase-triggered assembly of near-infrared II photoacoustic/photothermal nanotheranostics |
ACS Applied Materials and Interfaces. 2024 Aug 7;16(31):40611-40627. |
|
| 2024-07-27 |
Current advances of oral cancer in Taiwan |
Oral Diseases. 2024 Jul 27;Article in Press. |
|
